The high prevalence of UI results in a high overall cost of treatment. The annual cost to the NHS for community dwelling women in 2000 was estimated as £233 million with a further £178 million borne by individuals for self management. (1)
Urinary Incontinence (UI) is ‘the complaint of any involuntary loss of urine’. The most common form is stress UI, which is loss of urine on effort or physical exertion (e.g. sporting activities) or on coughing or sneezing.(2)
UI is distressing and socially disruptive. It may be the cause of personal health and hygiene problems. It may restrict employment and educational or leisure opportunities.(3) UI substantially increases the risk of hospitalisation and admission to a nursing home.(4) It is widely understood that UI is a sensitive health issue and many women delay treatment for many years due to embarrassment or shame. Women may believe that UI is inevitable after childbirth or with advancing age and may not be aware of treatment options.(5)
Physiotherapy is clinically effective
More on incontinence and physiotherapy
Information aimed at patients and carers:
- Training and strengthening the pelvic floor muscles (the muscles that support the bladder and urethra) is recommended as first-line management for women with stress, urge or a mixture of stress and urge urinary incontinence.(3)
- It is also recommended that it should also be offered to women in their first pregnancy as a preventive strategy for UI.
- Physiotherapists give advice(6), to women with UI, on key public health messages that improve lifestyle and wellbeing including; weight loss, reduction of caffeine / fluid intake, cessation of smoking and an increase in physical exercise.
Physiotherapy is cost effective
An economic evaluation comparing pelvic floor muscle training to Duloxetine, a drug used to treat UI, showed that the pelvic floor training ‘dominated’ Duloxetine, being cheaper and more clinically effective.(7)
A recent health technology assessment reviewed the clinical evidence and modelled several non-surgical strategies. The results showed that more intensive pelvic floor muscle training, for example by delivering extra sessions (more than two per month), plus lifestyle changes was the most clinical and cost effective first line strategy.(8) This combination had a very high probability of having a cost per QALY * significantly below the level usually considered to be affordable in the NHS (about £20,000 to £30,000 per QALY).(9)
A study evaluated the clinical effectiveness and costs of physiotherapy sessions in a group compared with the same sessions delivered to individuals. The group sessions had comparable health outcomes and notably lower costs (£8 compared to £53 per patient).(10)
* QALY = Quality Adjusted Life Year -meaning an extra year of healthy life expectancy
Size of the problem
- It has been estimated that UI affects 20.4% of people aged 40 years and over, equivalent to 5 million people in the UK, although not all may need or want help.(12) In women this figure increases to 35.6% at age 80 and over.
- 50% of women reporting incontinence were moderately or greatly bothered by it
- 27% were unwilling to go to places where they were unsure about the availability of toilets
- 31% dressed differently because of the problem
- 23% said it affected their sex life
- 23% said it reduced their activity levels
- 25% described feelings of frustration and/or embarrassment.(12)
Self referral project
Self referral (SR) is a system of access that allows the patient to refer themselves directly to a physiotherapist without being referred by another health professional. A recent project evaluating the benefit of SR for women with bladder or pelvic floor problems was shown to:
- Deliver a more responsive service with wider access
- Empower service users and achieve greater levels of attendance
- Be well accepted by service users, who reported high levels of satisfaction.(11)
The greater access provided by SR is in line with current health policy, with SR included as a requirement in the service specification for the Any Qualified Provider national implementation pack for continence services.
UI has a major impact on quality of life and affects a significant number of women. Contact with a physiotherapist offers both recommended first line treatment for UI and health promotion and prevention strategies, and has been proven to be both clinically and cost effective.
More resources for GPs:
The CSP would like to thank: Teresa Cook (Women’s Health Physiotherapist) and Joyce Craig (Craig Health Economics Consultancy Limited). Updated 2014 by Doreen McClurg & POGP
1. Papanicolaou S, Pons M, Hampel C, et al. Medical resource utilisation and cost of care for women seeking treatment for urinary incontinence in an outpatient setting. Examples from three countries participating in the PURE study. Maturitas. 2005 Nov 30;52 (Suppl 2):S35-47.
2. Haylen B, de Ridder D, Freeman R, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn. 2010;29(1):4-20.
3. National Institute for Health and Clinical Excellence. Urinary incontinence: the management of urinary incontinence in women. CG171. London: National Institute for Health and Clinical Excellence; 2013. http://guidance.nice.org.uk/CG171
4. Thom DH, Haan MN, Van Den Eeden SK. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing. 1997;26(5):36774.
5. Shaw C BR, Allan R, Jackson C, Hyde C,. Barriers to help -seeking in people with urinary problems Family Practitioner. 2001;18(48-52) http://fampra.oxfordjournals.org/content/18/1/48.short
6. Boyle R, Hay-Smith EJC, Cody June D, et al. Pelvic floor muscle training for prevention and treatment of urinary and faecal incontinence in antenatal and postnatal women. Cochrane Database of Systematic Reviews. 2012(10) http://onlinelibrary.wiley.com/ doi/10.1002/14651858.CD007471.pub2/abstract
7. Brunenberg DE, Joore MA, Veraart CP, et al. Economic evaluation of duloxetine for the treatment of women with stress urinary incontinence: a Markov model comparing pharmacotherapy with pelvic floor muscle training. Clin Ther. 2006 Apr;28(4):604-18.
8. Imamura M, Abrams P, Bain C, et al. Systematic review and economic modelling of the effectiveness and cost-effectiveness of non-surgical treatments for women with stress urinary incontinence. Health Technol Assess. 2010 Aug;14(40):1-188, iii-iv. http://www.journalslibrary.nihr.ac.uk/hta/volume-12/issue-26
9. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: National Institute for Health and Clinical Excellence; 2013. http://publications.nice.org.uk/guide-to-the-methods-of-technology-appraisal-2013-pmg9/the-reference-case
10. Lamb S, Pepper J, Lall R, et al. Group treatments for sensitive health care problems: a randomised controlled trial of group versus individual physiotherapy sessions for female urinary incontinence. BMC Womens Health. 2009;9:26. http://www.biomedcentral.com/1472-6874/9/26
11. The Chartered Society of Physiotherapy. Project to evaluate patient self-referral to women’s health physiotherapy pilot sites (PD105). London: The Chartered Society of Physiotherapy ;2013 http://www.csp.org.uk/publications/patient-self-referral-womens-health-pilot
12. McGrother C, Donaldson M, Shaw C, et al. Storage symptoms of the bladder: prevalence, incidence and need for services in the UK. BJU International. 2004 Apr;93(6):763-9.